Organ specificity of the bladder carcinogen 4-aminobiphenyl in inducing DNA damage and mutation in mice

Cancer Prevention Research

Volumn 5, Issue 2, 2012, Pages 299-308

  Yoon, Jae In ^a   Kim, Sang In ^a   Tommasi, Stella ^a   Besaratinia, Ahmad ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 BIPHENYLAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; BLADDER; CONTROLLED STUDY; DNA DAMAGE; DNA DETERMINATION; DNA SEQUENCE; KIDNEY; LIVER; MALE; MOUSE; MUTAGENESIS; MUTAGENICITY; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE;

AMINOBIPHENYL COMPOUNDS; ANIMALS; CARCINOGENS; DNA ADDUCTS; DNA DAMAGE; DNA REPAIR; MALE; MICE; MICE, INBRED C57BL; MUTAGENESIS; MUTATION; ORGAN SPECIFICITY; SURVIVAL RATE; TRANSCRIPTION FACTORS; URINARY BLADDER NEOPLASMS; VIRAL PROTEINS;

EID: 84863229172     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-11-0309     Document Type: Article

References (51)

1. Beland FA, Kadlubar FF. Metabolic activation and DNA adducts of aromatic amines and nitroaromatic hydrocarbons. In: Cooper CS, Grover PL, editors. Chemical carcinogenesis and mutagenesis Berlin/ Heidelberg: Springer-Verlag; 1990. p. 297-325.
2. Ren L. Blasengeschw€ulste bei Fuchsin-Arbeitern. Arch Klin Chir, 50: 588-600; 1895.
3. Reprinted in translation: Shimkin MB (1980). Some classics of experimental oncology: 1950 selections, 1775-1965.NIH publication no 1980-2150, 1944-1951, 1895.
4. Leichtenstern O. Uber Harnblasenentz€undung und Harnblasengeschw€ulste bei Arbeitern in Farbfabriken. Deut Med Wochenschr 1898;24:709-13.
5. Parkes HG, Evans AEJ. Epidemiology of aromatic amine cancers. In: Searle CE, editor. Chemical carcinogens. Washington DC: American Chemical Society; 1984. p. 277-301.
6. Huepper WC, Wiely FH, Wolfe HD, Ranta KE, Leming MF, Blood FR. Experimental production of bladder tumors in dogs by administration of β-naphthylamine. J Ind Hyg Toxicol 1938;20:46-84.
7. Spitz S, Maguigan WH, Dobriner K. The carcinogenic action of benzidine. Cancer 1950;3:789-804.
8. Walpole AL, Williams MHC, Roberts DC. Tumours of the urinary bladder in dogs after ingestion of 4-aminodiphenyl. Br J Indust Med 1954;9:105-9.
9. International Agency for Research on Cancer. Some aromatic amines, hydrazine and related substances, N-nitroso compounds and miscellaneous alkylating agents. 2-Naphthylamine. Lyon (France): 1974.
10. Steineck G, Plato N, Norell SE, Hogstedt C. Urothelial cancer and some industry-related chemicals: an evaluation of the epidemiologic literature. Am J Ind Med 1990;17:371-91. (Pubitemid 20155400)
11. Patrianakos C, Hoffman D. Chemical studies on tobacco smoke LXIV. On the analysis of aromatic amines in cigarette smoke. J Anal Chem 1979;3:150-4. (Pubitemid 9242012)
12. Besaratinia A, Pfeifer GP. Second-hand smoke and human lung cancer. Lancet Oncol 2008;9:657-66. (Pubitemid 351878051)
13. Clavel J, Cordier S, Boccon-Gibod L, Hemon D. Tobacco and bladder cancer in males: increased risk for inhalers and smokers of black tobacco. Int J Cancer 1989;44:605-10. (Pubitemid 19258731)
14. D'Avanzo B, Negri E, La Vecchia C, Gramenzi A, Bianchi C, Franceschi S, et al. Cigarette smoking and bladder cancer. Eur J Cancer 1990;26:714-8. (Pubitemid 20275107)
15. Vineis P, Esteve J, Hartge P, Hoover R, Silverman DT, Terracini B. Effects of timing and type of tobacco in cigarette-induced bladder cancer. Cancer Res 1988;48:3849-52.
16. Kadlubar FF, Beland FA, Beranek DT, Dooley KL, Heflich RH, Evans FE. Arylamine-DNA adduct formation in relation to urinary bladder carcinogenesis and Salmonella typhimurium mutagenesis. In: Sugimura T, Kondo S, Takebe H, editors. Environmental mutagens and carcinogens. New York, NY: Alan R. Liss; 1982. p. 385-96.
17. Talaska G, al-Juburi AZ, Kadlubar FF. Smoking related carcinogen- DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct. Proc Natl Acad Sci U S A 1991;88:5350-4. (Pubitemid 21914742)
18. McMahon RE, Turner JC, Whitaker GW. The N-hydroxylation and ring-hydroxylation of 4-aminobiphenyl in vitro by hepatic mono-oxygenases from rat, mouse, hamster, rabbit and guinea-pig. Xenobiotica 1980;10:469-81. (Pubitemid 10016490)
19. Ziegler DM, Ansher SS, Nagata T, Kadlubar FF, Jakoby WB. N-methylation: potential mechanism for metabolic activation of carcinogenic primary arylamines. Proc Natl Acad Sci U S A 1988;85: 2514-7.
20. Kadlubar FF, Butler MA, Hayes BE, Beland FA, Guengerich FP. Role of microsomal cytochromes P-450 and prostaglandin H synthase in 4-aminobiphenyl-DNA adduct formation. In: Miners J, Birkett DJ, Drew R, McManus M, editors. Microsomes and drug oxidations. London, England: Taylor and Francis; 1988. p. 370-9.
21. Chou HC, Lang NP, Kadlubar FF. Metabolic activation of the N-hydroxy derivative of the carcinogen 4-aminobiphenyl by human tissue sulfotransferases. Carcinogenesis 1995;16:413-7.
22. Orzechowski A, Schrenk D, Bock-Hennig BS, Bock KW. Glucuronidation of carcinogenic arylamines and their N-hydroxy derivatives by rat and human phenol UDP-glucuronosyltransferase of the UGT1 gene complex. Carcinogenesis 1994;15:1549-53. (Pubitemid 24262138)
23. Poupko JM, Hearn WL, Radomski JL. N-Glucuronidation of N-hydroxy aromatic amines: a mechanism for their transport and bladder-specific carcinogenicity. Toxicol Appl Pharmacol 1979; 50:479-84. (Pubitemid 10193912)
24. Frederickson SM, Hatcher JF, Reznikoff CA, Swaminathan S. Acetyl transferase-mediated metabolic activation of N-hydroxy-4-aminobiphenyl by human uroepithelial cells. Carcinogenesis 1992;13: 955-61.
25. Swaminathan S, Reznikoff CA. Metabolism and nucleic acid binding of N-hydroxy-4-acetylaminobiphenyl and N-acetoxy-4-acetylaminobiphenyl by cultured human uroepithelial cells. Cancer Res 1992;52: 3286-94.
26. Besaratinia A, Pfeifer GP. Investigating human cancer etiology by DNA lesion footprinting and mutagenicity analysis. Carcinogenesis 2006; 27:1526-37. (Pubitemid 44288041)
27. Lambert IB, Singer TM, Boucher SE, Douglas GR. Detailed review of transgenic rodent mutation assays. Mutat Res 2005;590:1-280. (Pubitemid 41121981)
28. al-Atrash J, Zhang YJ, Lin D, Kadlubar FF, Santella RM. Quantitative immunohistochemical analysis of 4-aminobiphenyl-DNA in cultured cells and mice: comparison to gas chromatography/mass spectroscopy analysis. Chem Res Toxicol 1995;8:747-52.
29. Jakubczak JL, Merlino G, French JE, Muller WJ, Paul B, Adhya S, et al. Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage lambda transgene target. Proc Natl Acad Sci U S A 1996;93: 9073-8. (Pubitemid 26282020)
30. Pfeifer GP, Chen HH, Komura J, Riggs AD. Chromatin structure analysis by ligation-mediated and terminal transferase-mediated polymerase chain reaction. Methods Enzymol 1999;304: 548-71. (Pubitemid 29268903)
31. Besaratinia A, Yoon JI, Schroeder C, Bradforth SE, Cockburn M, Pfeifer GP. Wavelength dependence of ultraviolet radiation-induced DNA damage as determined by laser irradiation suggests that cyclobutane pyrimidine dimers are the principal DNA lesions produced by terrestrial sunlight. FASEB J 2011;25:3079-91.
32. Herskowitz I, Hagen D. The lysis-lysogeny decision of phage lambda: explicit programming and responsiveness. Annu Rev Genet 1980;14: 399-445.
33. Adams WT, Skopek TR. Statistical test for the comparison of samples from mutational spectra. J Mol Biol 1987;194:391-6. (Pubitemid 17081564)
34. Mirsalis JC, Shimon JA, Johnson A, Fairchild D, Kanazawa N, Nguyen T, et al. Evaluation of mutant frequencies of chemically induced tumors and normal tissues in lambda/cII transgenic mice. Environ Mol Mutagen 2005;45:17-35. (Pubitemid 40209392)
35. Schieferstein GJ. Carcinogenesis of 4-aminobiphenyl in mice. Jefferson, AR: National Center for Toxicological Research; 1983.
36. Schieferstein GJ, Littlefield NA, Gaylor DW, Sheldon WG, Burger GT. Carcinogenesis of 4-aminobiphenyl in BALB/cStCrlfC3Hf/Nctr mice. Eur J Cancer Clin Oncol 1985;21:865-73. (Pubitemid 15028514)
37. Poirier MC, Fullerton NF, Smith BA, Beland FA. DNA adduct formation and tumorigenesis in mice during the chronic administration of 4- aminobiphenyl at multiple dose levels. Carcinogenesis 1995;16: 2917-21. (Pubitemid 26004186)
38. Flammang TJ, Couch LH, Levy GN, Weber WW, Wise CK. DNA adduct levels in congenic rapid and slow acetylator mouse strains following chronic administration of 4-aminobiphenyl. Carcinogenesis 1992;13: 1887-91.
39. Chen T, Mittelstaedt RA, Beland FA, Heflich RH, Moore MM, Parsons BL. 4-Aminobiphenyl induces liver DNA adducts in both neonatal and adult mice but induces liver mutations only in neonatal mice. Int J Cancer 2005;117:182-7. (Pubitemid 41377436)
40. Farmer PB, Brown K, Tompkins E, Emms VL, Jones DJ, Singh R, et al. DNA adducts: mass spectrometry methods and future prospects. Toxicol Appl Pharmacol 2005;207:293-301.
41. Phillips DH, Arlt VM. The 32P-postlabeling assay for DNA adducts. Nat Protoc 2007;2:2772-81.
42. Fletcher K, Tinwell H, Ashby J. Mutagenicity of the human bladder carcinogen 4-aminobiphenyl to the bladder of Muta Mouse transgenic mice. Mutat Res 1998;400:245-50. (Pubitemid 28440226)
43. Zayas-Rivera B, Zhang L, Grant SG, Keohavong P, Day BW. Mutational spectrum of N-hydroxy-N-acetyl-4-aminobiphenyl at exon 3 of the HPRT gene. Biomarker 2001;6:262-73. (Pubitemid 32640523)
44. Besaratinia A, Bates SE, Pfeifer GP. Mutational signature of the proximate bladder carcinogen N-hydroxy-4-acetylaminobiphenyl: inconsistency with the p53 mutational spectrum in bladder cancer. Cancer Res 2002;62:4331-8. (Pubitemid 34827290)
45. Broyde S, Hingerty BE, Srinivasan AR. Influence of the carcinogen 4-aminobiphenyl on DNA conformation. Carcinogenesis 1985;6: 719-25. (Pubitemid 15064173)
46. Shapiro R, Underwood GR, Zawadzka H, Broyde S, Hingerty BE. Conformation of d(CpG) modified by the carcinogen 4-aminobiphenyl: a combined experimental and theoretical analysis. Biochemistry 1986;25:2198-205. (Pubitemid 16036037)
47. Drake JW, Baltz RH. The biochemistry of mutagenesis. Annu Rev Biochem 1976;45:11-37.
48. Topal MD, Fresco JR. Complementary base pairing and the origin of substitution mutations. Nature 1976;263:285-9.
49. Manjanatha MG, Li EE, Fu PP, Heflich RH. H- and K-ras mutational profiles in chemically induced liver tumors from B6C3F1 and CD-1 mice. J Toxicol Environ Health 1996;47:195-208.
50. Melchior WB Jr, Marques MM, Beland FA. Mutations induced by aromatic amine DNA adducts in pBR322. Carcinogenesis 1994; 15:889-99. (Pubitemid 24156886)
51. Verghis SB, Essigmann JM, Kadlubar FF, Morningstar ML, Lasko DD. Specificity of mutagenesis by 4-aminobiphenyl: mutations at G residues in bacteriophage M13 DNA and G->C transversions at a unique dG(8-ABP) lesion in single-stranded DNA. Carcinogenesis 1997;18: 2403-14. (Pubitemid 28134656)